Vitamin D status, incident diabetes and prospective changes in glucose metabolism in older subjects: the Hoorn study.

[1]  E. Barrett-Connor,et al.  Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  A. Doney,et al.  The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[3]  S. Pilz,et al.  Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[4]  S. Booth,et al.  Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study , 2012, European Journal of Clinical Nutrition.

[5]  M. Woodward,et al.  Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds , 2012, Diabetologia.

[6]  W. März,et al.  Vitamin D, cardiovascular disease and mortality , 2011, Clinical endocrinology.

[7]  R. Jorde,et al.  Vitamin D, Insulin Secretion, Sensitivity, and Lipids , 2011, Diabetes.

[8]  B. Zinman,et al.  Prospective Associations of Vitamin D With β-Cell Function and Glycemia , 2011, Diabetes.

[9]  J. Souberbielle,et al.  Vitamin D and type 2 diabetes mellitus: where do we stand? , 2011, Diabetes & metabolism.

[10]  F. Hu,et al.  Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. , 2011, The American journal of clinical nutrition.

[11]  J. Mitri,et al.  Vitamin D and type 2 diabetes: a systematic review , 2011, European Journal of Clinical Nutrition.

[12]  A. Mosca,et al.  The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[13]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[14]  C. Dalgård,et al.  Vitamin D Status in Relation to Glucose Metabolism and Type 2 Diabetes in Septuagenarians , 2011, Diabetes Care.

[15]  J. Shaw,et al.  Serum 25-Hydroxyvitamin D, Calcium Intake, and Risk of Type 2 Diabetes After 5 Years , 2011, Diabetes Care.

[16]  Jennifer G. Robinson,et al.  Lack of Association Between 25(OH)D Levels and Incident Type 2 Diabetes in Older Women , 2011, Diabetes Care.

[17]  P. Strazzullo,et al.  Should vitamin D status be assessed in patients with congestive heart failure? , 2010, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[18]  I. Njølstad,et al.  Baseline serum 25‐hydroxyvitamin D concentrations in the Tromsø Study 1994–95 and risk of developing type 2 diabetes mellitus during 11 years of follow‐up , 2010, Diabetic medicine : a journal of the British Diabetic Association.

[19]  J. Manson,et al.  Plasma 25-Hydroxyvitamin D Concentration and Risk of Incident Type 2 Diabetes in Women , 2010, Diabetes Care.

[20]  W. März,et al.  Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. , 2010, European heart journal.

[21]  S. Booth,et al.  Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. , 2010, The American journal of clinical nutrition.

[22]  R. Jorde,et al.  Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. , 2010, American journal of epidemiology.

[23]  G. Nijpels,et al.  Ten-year time course of risk factors for increased carotid intima–media thickness: the Hoorn Study , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[24]  V. Freeman,et al.  Association of A1C Levels With Vitamin D Status in U.S. Adults , 2010, Diabetes Care.

[25]  C. Drevon,et al.  Serum Vitamin D Concentration Does Not Predict Insulin Action or Secretion in European Subjects With the Metabolic Syndrome , 2010, Diabetes Care.

[26]  G. Nijpels,et al.  Vitamin D and mortality in older men and women , 2009, Clinical endocrinology.

[27]  E. Ford,et al.  Associations of Serum Concentrations of 25-Hydroxyvitamin D and Parathyroid Hormone With Surrogate Markers of Insulin Resistance Among U.S. Adults Without Physician-Diagnosed Diabetes: NHANES, 2003–2006 , 2009, Diabetes Care.

[28]  J. Coad,et al.  Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial , 2009, British Journal of Nutrition.

[29]  A. Avenell,et al.  Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). , 2009, Age and ageing.

[30]  R. Koerfer,et al.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. , 2009, The American journal of clinical nutrition.

[31]  R. Jorde,et al.  Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels , 2009, European journal of nutrition.

[32]  J. Nagpal,et al.  A double‐blind, randomized, placebo‐controlled trial of the short‐term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle‐aged, centrally obese men , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[33]  A. Reunanen,et al.  Serum Vitamin D and Subsequent Occurrence of Type 2 Diabetes , 2008, Epidemiology.

[34]  N. Wareham,et al.  Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance , 2008, Diabetes.

[35]  C. Mathieu,et al.  Vitamin D and human health: lessons from vitamin D receptor null mice. , 2008, Endocrine reviews.

[36]  B. Kestenbaum,et al.  Calcium plus vitamin D supplementation and the risk of incident diabetes mellitus in the Women ’ s Health Initiative , 2008 .

[37]  A. Mitrakou,et al.  The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults , 2007, Diabetes Care.

[38]  Tom Greene,et al.  Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.

[39]  W. Saris,et al.  Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. , 2003, Journal of clinical epidemiology.

[40]  C. Thomas,et al.  PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. , 2003, Medical hypotheses.